Incidence and Influencing Factors of In‐Stent Restenosis After Percutaneous Coronary Intervention in Patients With Coronary Artery Disease: A Systematic Review and Meta‐Analysis

Documenti analoghi

• Ticagrelor Versus Clopidogrel in Patients With Chronic Coronary Syndrome Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta‐Analysis
  di: Johann Bill Pinedo‐Avila, et al.
  Pubblicazione: (2025)
• Paclitaxel‐Coated Balloon for the Management of In‐Stent Coronary Restenosis: An Updated Meta‐Analysis and Trial Sequential Analysis
  di: Vinícius M. R. Oliveira, et al.
  Pubblicazione: (2025)
• Methodological Considerations in Assessing Coronary Flow Reserve After Percutaneous Coronary Intervention
  di: Maheen Rizwan
  Pubblicazione: (2025)
• Risk Profile and Prognostic Implications of Percutaneous Coronary Intervention Procedure Failure in Patients With Moderate‐to‐Severe Coronary Artery Calcification
  di: Zhangyu Lin, et al.
  Pubblicazione: (2025)
• Long‐Term Outcomes After Percutaneous Coronary Intervention With the Polymer‐Free Biolimus‐Coated BioFreedom Stent Versus the Biodegradable‐Polymer Sirolimus‐Eluting Orsiro Stent in Patients With Acute Coronary Syndromes
  di: Manijeh Noori, et al.
  Pubblicazione: (2026)